From: Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis
eGFR < 90 mL/min/1,73 m2 | eGFR 90–119 mL/min/1.73 m2 | eGFR > 120 mL/min/1.73 m2 | Total | |
---|---|---|---|---|
Mutationclass I | 25% (7 pts) | 39.3% (11 pts) | 35.7% (10 pts) | 28 |
Mutationclass II | 24.7% (39 pts) | 45.6% (72 pts) | 29.7% (47 pts) | 158 |
Mutationclass III | 0 | 66.7% (2 pts) | 33.3% (1 pts) | 3 |
Mutationclass IV | 62.5% (5 pts) | 25% (2 pts) | 12.5% (1 pts) | 8 |
Mutationclass V | 33.3% (4 pts) | 41.7% (5 pts) | 25% (3 pts) | 12 |
Total | 26.3% (55 pts) | 44% (92 pts) | 29.7% (62 pts) | 209 |
p value (using Chi squared test (χ2 8df) | 0.467 |